01. NIH (1986) Therapy of lupus nephritis. Controlled trial of prednisone and cytotoxic drugs.
02. BOUPAS et al (1992) Controlled trial of pulse methylprednisolone versus two regimens of pulse cyclophosphamide in severe lupus nephritis.
03. GOURLEY (1996) Methylprednisolone and cyclophosphamide, alone or in combination, in patients with lupus nephritis. A randomized, controlled trial.
04. CHAN et al (2000) Efficacy of Mycophenolate Mofetil in Patients with Diffuse Proliferative Lupus Nephritis.
05. EUROLUPUS (2002) Immunosuppressive therapy in lupus nephritis: the Euro-Lupus Nephritis Trial, a randomized trial of low-dose versus high-dose intravenous cyclophosphamide.
06. ALMS Trial(2009) Mycophenolate Mofetil versus Cyclophosphamide for Induction Treatment of Lupus Nephritis.
07. ALMS Maintenance Trial(2011) Mycophenolate versus Azathioprine as Maintenance Therapy for Lupus Nephritis.
08. LUNAR (2012) Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: the Lupus Nephritis Assessment with Rituximab study.
09. LUI et al (2015) Multitarget Therapy for Induction Treatment of Lupus Nephritis: A Randomized Trial.
10. AURA-LV (2018) A randomized, controlled double-blind study comparing the efficacy and safety of dose-ranging voclosporin with placebo in achieving remission in patients with active lupus nephritis.
11. BLISS LN (2020) Two-Year, Randomized, Controlled Trial of Belimumab in Lupus Nephritis.
12. MDT Multitarget Therapy for Maintenance Treatment of Lupus Nephritis.
